keyword
https://read.qxmd.com/read/38634042/erratum
#1
(no author information available yet)
[This corrects the article DOI: 10.1159/000534044.].
2024: Medical cannabis and cannabinoids
https://read.qxmd.com/read/38600591/factors-associated-with-the-use-of-cannabis-for-self-medication-by-adults-data-from-the-french-tempo-cohort-study
#2
JOURNAL ARTICLE
Solène Wallez, Isabelle Kousignian, Irwin Hecker, Selma Faten Rezag Bara, Astrid Juhl Andersen, Maria Melchior, Jean-Sébastien Cadwallader, Murielle Mary-Krause
BACKGROUND: Medical cannabis, legalized in many countries, remains illegal in France. Despite an experiment in the medical use of cannabis that began in March 2021 in France, little is known about the factors associated with the use of cannabis for self-medication among adults. METHODS: Data came from the French TEMPO cohort and were collected between December 2020 and May 2021. Overall, 345 participants aged 27-47 were included. Cannabis for self-medication was defined using the following questions: 'Why do you use cannabis?' and 'In what form do you use cannabis?'...
April 10, 2024: Journal of cannabis research
https://read.qxmd.com/read/38589855/canadians-use-of-cannabis-for-therapeutic-purposes-since-legalization-of-recreational-cannabis-a-cross-sectional-analysis-by-medical-authorization-status
#3
JOURNAL ARTICLE
Lynda G Balneaves, Ashleigh Brown, Matthew Green, Erin Prosk, Lucile Rapin, Max Monahan-Ellison, Eva McMillan, Jonathan Zaid, Michael Dworkind, Cody Z Watling
BACKGROUND: There has been a precipitous decline in authorizations for medical cannabis since non-medical cannabis was legalized in Canada in 2018. This study examines the demographic and health- and medical cannabis-related factors associated with authorization as well as the differences in medical cannabis use, side effects, and sources of medical cannabis and information by authorization status. METHODS: Individuals who were taking cannabis for therapeutic purposes completed an online survey in early 2022...
April 8, 2024: BMC Medicine
https://read.qxmd.com/read/38586531/medical-cannabis-use-and-its-impact-on-health-among-older-adults-recent-research-findings-and-future-directions
#4
JOURNAL ARTICLE
Yan Wang, Kendall R Robinson, Hannah Fechtel, Alexis Hartog
PURPOSE OF REVIEW: With the rapidly changing landscape of state level legalization of cannabis, older adults have become one of the fastest growing populations seeking medical cannabis (MC). However, research evidence on the risks and benefits of MC use in this population remains limited. This review aims to synthesize recent literature on the impacts of MC use in older adults and identify critical knowledge gaps to be addressed in future research. RECENT FINDINGS: Recent literature showed that older adults often face financial and/or educational barriers and stigma associated with MC access...
December 2023: Current Addiction Reports
https://read.qxmd.com/read/38570361/unveiling-the-link-between-chronic-pain-and-misuse-of-opioids-and-cannabis
#5
REVIEW
Merel Dagher, Myra Alayoubi, Gabriella H Sigal, Catherine M Cahill
Over 50 million Americans endure chronic pain where many do not receive adequate treatment and self-medicate to manage their pain by taking substances like opioids and cannabis. Research has shown high comorbidity between chronic pain and substance use disorders (SUD) and these disorders share many common neurobiological underpinnings, including hypodopaminergic transmission. Drugs commonly used for self-medication such as opioids and cannabis relieve emotional, bothersome components of pain as well as negative emotional affect that perpetuates misuse and increases the risk of progressing towards drug abuse...
April 3, 2024: Journal of Neural Transmission
https://read.qxmd.com/read/38562089/medical-marijuana-laws-and-mental-health-in-the-united-states
#6
JOURNAL ARTICLE
Jörg Kalbfuss, Reto Odermatt, Alois Stutzer
The consequences of legal access to medical marijuana for individuals' well-being are controversially assessed. We contribute to the discussion by evaluating the impact of the introduction of medical marijuana laws across US states on self-reported mental health considering different motives for cannabis consumption. Our analysis is based on BRFSS survey data from close to eight million respondents between 1993 and 2018 that we combine with information from the NSDUH to estimate individual consumption propensities...
April 2, 2024: Health Economics, Policy, and Law
https://read.qxmd.com/read/38551244/assessing-dental-student-knowledge-on-cannabis-and-demonstrating-the-need-for-cannabis-education
#7
JOURNAL ARTICLE
Jessica S Kruger, John Lepore, Madelyn Mascaro, Gina Mersereau, Alyssa Tzetzo, Daniel J Kruger
PURPOSE: The American Dental Association advocates for dentists' education on therapeutic and legal issues related to medical cannabis. It is important to understand current knowledge of cannabis and cannabinoids and to have a practical knowledge assessment instrument. This exploratory study is the first of its kind to assess dental students' knowledge of cannabis and aims to determine if there is a need for more instruction regarding cannabis in a dental school's curriculum. METHODS: Predoctoral dental students at the University at Buffalo School of Dental Medicine were recruited to participate...
March 29, 2024: Journal of Dental Education
https://read.qxmd.com/read/38546082/health-literacy-and-demand-for-medical-cannabis-use-among-colorectal-cancer-patients-in-northern-thailand-a-cross-sectional-study
#8
JOURNAL ARTICLE
Alongkorn Sukrueangkul, Petcherut Sirisuwan, Kanlayawee Anonjarn, Punrada Poungsamai, Suchitra Hudrudchai, Napapat Thongkamwong, Poramate Insook, Patitta Suangpho
OBJECTIVE: This study aimed to explore health literacy and factors associated with demand for medical cannabis (MC) use among colorectal cancer (CRC) patients in Northern Thailand as a target group. METHODS: This cross-sectional analytical study administered multistage random sampling to recruit 439 CRC patients in northern Thailand. Ethical approval and signed written informed consents were obtained from the patients, prior to the study. A standardized, self-administered structured questionnaire was used to obtain the sociodemographic characteristics, clinical characteristics, social support, attitudes toward MC, knowledge about MC, health literacy about MC, and questions on demand for MC use...
March 1, 2024: Asian Pacific Journal of Cancer Prevention: APJCP
https://read.qxmd.com/read/38542886/chemistry-and-pharmacology-of-delta-8-tetrahydrocannabinol
#9
REVIEW
Maged S Abdel-Kader, Mohamed M Radwan, Ahmed M Metwaly, Ibrahim H Eissa, Arno Hazekamp, Mahmoud A ElSohly
Cannabis sativa is one of the oldest plants utilized by humans for both economic and medical purposes. Although the use of cannabis started millennia ago in the Eastern hemisphere, its use has moved and flourished in the Western nations in more recent centuries. C. sativa is the source of psychoactive cannabinoids that are consumed as recreational drugs worldwide. The C21 aromatic hydrocarbons are restricted in their natural occurrence to cannabis (with a few exceptions). Delta-9-tetrahydrocannabinol (Δ9 -THC) is the main psychoactive component in cannabis, with many pharmacological effects and various approved medical applications...
March 11, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38538449/assessment-of-education-in-a-community-hospital-on-healthcare-providers-knowledge-of-and-attitudes-toward-medical-marijuana
#10
JOURNAL ARTICLE
Sierra Meyers, Kisha Gant, Melissa Burmeister
INTRODUCTION: Although medical marijuana usage continues to become more socially acceptable and is increasingly regarded as a legitimate treatment alternative for certain medical conditions such as cancer and epilepsy, stigma remains. METHODS: This study examined whether offering an educational session addressing several key aspects of medical marijuana (e.g., pharmacology, legality) to healthcare providers in a community hospital setting improved knowledge about and/or altered attitudes toward marijuana use...
March 26, 2024: Currents in Pharmacy Teaching & Learning
https://read.qxmd.com/read/38532499/state-licenses-for-medical-marijuana-dispensaries-neighborhood-level-determinants-of-applicant-quality-in-missouri
#11
JOURNAL ARTICLE
David M Yaskewich
BACKGROUND: When state governments impose quotas on commercial marijuana licenses, regulatory commissions use an application process to assess the feasibility of prospective businesses. Decisions on license applications are often met with formal appeals and legal challenges from rejected applicants. Although prior research has examined substate disparities in the availability of marijuana dispensaries, less attention has been given to the quality of license applications. The present study analyzed the relationship between neighborhood-level characteristics and the quality of prospective dispensary businesses...
March 26, 2024: Journal of cannabis research
https://read.qxmd.com/read/38532234/stigma-risks-and-benefits-of-medicinal-cannabis-use-among-australians-with-cancer
#12
JOURNAL ARTICLE
Julia N Morris, Jessica Loyer, Jason Blunt
PURPOSE: People with cancer who use medicinal cannabis do so despite risks associated with limited clinical evidence, legalities, and stigma. This study investigated how Australians with cancer rationalise their medicinal cannabis use despite its risks. METHODS: Ten adults (5 males and 5 females; mean age of 53.3) who used cannabis medicinally for their cancer were interviewed in 2021-2022 about how they used and accessed the substance, attitudes and beliefs underpinning their use, and conversations with others about medicinal cannabis...
March 27, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38519643/cannabis-use-after-a-cancer-diagnosis-in-a-population-based-sample-of-cancer-survivors
#13
JOURNAL ARTICLE
Mimi Ton, Polly A Newcomb, Salene Jones, Rachel C Malen, Jaimee L Heffner
PURPOSE: This study aimed to characterize the prevalence and correlates of cannabis use and the methods and reasons for use among recently diagnosed cancer survivors in a population sample within Washington state. METHODS: We identified individuals diagnosed with invasive cancers in the prior 6 to 17 months from April 2020 to December 2020 using the Seattle-Puget Sound Surveillance, Epidemiology, and End Results (SEER) cancer registry. Participants (n = 1,515) completed a questionnaire, including demographics, medical history, cannabis use, and other substance use...
March 22, 2024: Cancer Causes & Control: CCC
https://read.qxmd.com/read/38505273/fabrication-of-orally-fast-disintegrating-wafer-tablets-containing-cannabis-extract-using-freeze-drying-method
#14
JOURNAL ARTICLE
Chaowalit Monton, Poj Kulvanich, Natawat Chankana, Jirapornchai Suksaeree, Thanapat Songsak
INTRODUCTION: The development of a novel dosage form for cannabis extract is necessary to improve drug delivery and also enhance patient convenience. METHODS: Orally fast-disintegrating wafer tablets containing cannabis extract, which were prepared using the freeze drying technique, were developed in this work. The formulation consisted of several key components: cannabis extract as the active compound, Tween® 80 as a surfactant and solubilizer, gelatin and mannitol as structural components, sucralose as a sweetening agent, and sodium methylparaben and sodium propylparaben as preservatives...
2024: Medical cannabis and cannabinoids
https://read.qxmd.com/read/38500669/observational-analysis-of-the-influence-of-medical-marijuana-use-on-quality-of-life-in-patients
#15
JOURNAL ARTICLE
Mark D Kelley, Marwah Obaid, Edward M Miller, Marla Bowie, Zachary S Heeter
INTRODUCTION: A significant gap exists in the understanding and utilization of medical marijuana and its effects on a patient's quality of life. This is largely attributed to Cannabis' sp. Schedule 1 classification, which has impeded the scientific investigation of its effects on the endocannabinoid system (ECS) and quality of life. Additionally, conflicting results from previous studies highlight the need for more research to provide guidance to both patients and clinicians regarding the therapeutic potential of medical marijuana...
2024: Medical cannabis and cannabinoids
https://read.qxmd.com/read/38487377/dispensaries-and-medical-marijuana-certifications-and-indications-unveiling-the-geographic-connections-in-pennsylvania-usa
#16
JOURNAL ARTICLE
Annemarie G Hirsch, Eric A Wright, Cara M Nordberg, Joseph DeWalle, Elena L Stains, Amy L Kennalley, Joy Zhang, Lorraine D Tusing, Brian J Piper
INTRODUCTION: Pennsylvania opened its first medical marijuana (MMJ) dispensary in 2018. Qualifying conditions include six conditions determined to have no or insufficient evidence to support or refute MMJ effectiveness. We conducted a study to describe MMJ dispensary access in Pennsylvania and to determine whether dispensary proximity was associated with MMJ certifications and community demographics. METHODS: Using data from the Pennsylvania Department of Health, we geocoded MMJ dispensary locations and linked them to US Census Bureau data...
2024: Medical cannabis and cannabinoids
https://read.qxmd.com/read/38461280/evaluation-of-dispensaries-cannabis-flowers-for-accuracy-of-labeling-of-cannabinoids-content
#17
JOURNAL ARTICLE
Mona M Geweda, Chandrani G Majumdar, Malorie N Moore, Mostafa A Elhendawy, Mohamed M Radwan, Suman Chandra, Mahmoud A ElSohly
BACKGROUND: Cannabis policies have changed drastically over the last few years with many states enacting medical cannabis laws, and some authorizing recreational use; all against federal laws. As a result, cannabis products are marketed in dispensaries in different forms, most abundantly as flowers intended for smoking and sometimes vaping. All samples used in this study were obtained directly from law enforcement. The sample collection process was facilitated and funded by the National Marijuana Initiative (NMI), part of the High-Intensity Drug Trafficking Area (HIDTA) program...
March 9, 2024: Journal of cannabis research
https://read.qxmd.com/read/38433233/a-phase-iii-multisite-randomised-controlled-trial-to-compare-the-efficacy-of-cannabidiol-to-placebo-in-the-treatment-of-cannabis-use-disorder-the-cbd-cud-study-protocol
#18
JOURNAL ARTICLE
Anjali K Bhardwaj, Llew Mills, Michael Doyle, Arshman Sahid, Mark Montebello, Lauren Monds, Shalini Arunogiri, Paul Haber, Valentina Lorenzetti, Dan I Lubman, Peter Malouf, Mary E Harrod, Adrian Dunlop, Tom Freeman, Nicholas Lintzeris
BACKGROUND: Cannabis use disorder (CUD) is increasingly common and contributes to a range of health and social problems. Cannabidiol (CBD) is a non-intoxicating cannabinoid recognised for its anticonvulsant, anxiolytic and antipsychotic effects with no habit-forming qualities. Results from a Phase IIa randomised clinical trial suggest that treatment with CBD for four weeks reduced non-prescribed cannabis use in people with CUD. This study examines the efficacy, safety and quality of life of longer-term CBD treatment for patients with moderate-to-severe CUD...
March 4, 2024: BMC Psychiatry
https://read.qxmd.com/read/38421358/accuracy-and-replicability-of-identifying-eyelid-tremor-as-an-indicator-of-recent-cannabis-smoking
#19
JOURNAL ARTICLE
George Sam Wang, Michael Kosnett, Prem Subramanian, Julia Wrobel, Ming Ma, Tim Brown, L Cinnamon Bidwell, Ashley Brooks-Russell
INTRODUCTION: Cannabis intoxication may increase the risk of motor vehicle crashes. However, reliable methods of assessing cannabis intoxication are limited. The presence of eyelid tremors is among the signs of cannabis use identified under the Drug Evaluation and Classification Program of the International Association of Chiefs of Police. Our objectives were to assess the accuracy and replicability of identifying eyelid tremor as an indicator of recent cannabis smoking using a blinded, controlled study design...
January 2024: Clinical Toxicology
https://read.qxmd.com/read/38409714/association-between-cannabis-use-and-subjective-cognitive-decline-findings-from-the-behavioral-risk-factor-surveillance-system-brfss
#20
JOURNAL ARTICLE
Zhi Chen, Roger Wong
BACKGROUND: Cannabis consumption has rapidly increased in the United States due to more states legalizing non-medical and medical use. There is limited research, however, investigating whether cannabis may be associated with cognitive function, particularly across multiple dimensions of cannabis use. OBJECTIVE: The objective of this study was to examine whether cannabis consumption reason, frequency, and method are associated with subjective cognitive decline (SCD)...
February 23, 2024: Current Alzheimer Research
keyword
keyword
164200
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.